hydroxypropyl-gamma-cyclodextrin has been researched along with erythrosine in 1 studies
Studies (hydroxypropyl-gamma-cyclodextrin) | Trials (hydroxypropyl-gamma-cyclodextrin) | Recent Studies (post-2010) (hydroxypropyl-gamma-cyclodextrin) | Studies (erythrosine) | Trials (erythrosine) | Recent Studies (post-2010) (erythrosine) |
---|---|---|---|---|---|
86 | 0 | 34 | 15,483 | 108 | 2,574 |
Protein | Taxonomy | hydroxypropyl-gamma-cyclodextrin (IC50) | erythrosine (IC50) |
---|---|---|---|
Genome polyprotein | Zika virus | 1.7 | |
large T antigen | Betapolyomavirus macacae | 13.04 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antimisiaris, SG; Hatzi, P; Klepetsanis, PG; Mourtas, S | 1 |
1 other study(ies) available for hydroxypropyl-gamma-cyclodextrin and erythrosine
Article | Year |
---|---|
Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Chemistry, Pharmaceutical; Cholesterol; Cyclodextrins; Drug Compounding; Excipients; Fluoresceins; Fluorescent Dyes; gamma-Cyclodextrins; Lipids; Liposomes; Membrane Fluidity; Nanotechnology; Nephelometry and Turbidimetry; Particle Size; Phosphatidylcholines; Solubility; Technology, Pharmaceutical; Time Factors | 2007 |